Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Emma K Frow

Showing results (1-10 of 8) with videos related to

Pageof 1
Sort By:
EMBO Reports|April 2, 2009
A forum for 'doing society and genomics'. Science & Society Series on Convergence ResearchEmma K Frow
Plos One|September 17, 2021
Exploring presentations of sustainability by US synthetic biology companiesJames Karabin, Izaac Mansfield, Emma K Frow
Medicinal Research Reviews|March 3, 2004
Tools for anti-inflammatory drug design: in vitro models of leukocyte migrationEmma K Frow, Jill Reckless, David J Grainger
Current Opinion in Microbiology|December 14, 2025
Emerging governance considerations for the deployment of genetically engineered microbesAvery M Brewer, Dalton R George, Emma K Frow
Stem Cell Reports|November 12, 2021
Weighing up the evidence used by direct-to-consumer stem cell businessesMargaret Cook, Alexandra Richey, David A Brafman, et al.
Synthetic Biology (Oxford, England)|April 5, 2021
Building a biofoundryMaciej B Holowko, Emma K Frow, Janet C Reid, et al.
Nature Communications|January 20, 2024
A bumpy road ahead for genetic biocontainmentDalton R George, Mark Danciu, Peter W Davenport, et al.
Stem Cell Reports|August 6, 2019
Characterizing Direct-to-Consumer Stem Cell Businesses in the Southwest United StatesEmma K Frow, David A Brafman, Anna Muldoon, et al.
Pageof 1

Showing results (1-10 of 8) with videos related to

Sort By:
Pageof 1
EMBO Reports|April 2, 2009
A forum for 'doing society and genomics'. Science & Society Series on Convergence ResearchEmma K Frow
Plos One|September 17, 2021
Exploring presentations of sustainability by US synthetic biology companiesJames Karabin, Izaac Mansfield, Emma K Frow
Medicinal Research Reviews|March 3, 2004
Tools for anti-inflammatory drug design: in vitro models of leukocyte migrationEmma K Frow, Jill Reckless, David J Grainger
Current Opinion in Microbiology|December 14, 2025
Emerging governance considerations for the deployment of genetically engineered microbesAvery M Brewer, Dalton R George, Emma K Frow
Stem Cell Reports|November 12, 2021
Weighing up the evidence used by direct-to-consumer stem cell businessesMargaret Cook, Alexandra Richey, David A Brafman, et al.
Synthetic Biology (Oxford, England)|April 5, 2021
Building a biofoundryMaciej B Holowko, Emma K Frow, Janet C Reid, et al.
Nature Communications|January 20, 2024
A bumpy road ahead for genetic biocontainmentDalton R George, Mark Danciu, Peter W Davenport, et al.
Stem Cell Reports|August 6, 2019
Characterizing Direct-to-Consumer Stem Cell Businesses in the Southwest United StatesEmma K Frow, David A Brafman, Anna Muldoon, et al.
Pageof 1